We are live on ! Find out more
RVM

RiverVest Venture Management Portfolio holdings

AUM $6.84M Turnover 25%
1-Year Est. Return 7.71%
This Fund
S&P 500
This Quarter Est. Return
+5.51%
1 Year Est. Return
-7.71%
3 Year Est. Return
-16.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$27.1M
AUM Growth
-$13.3M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
2.7 years
Top 10 Avg Time Held
2.7 years
Top 20 Avg Time Held
2.7 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ALLK icon
1
DELISTED
Allakos
ALLK
$13.6M 50.21%
4,987,522
– –
2020 Q4
12 quarters
SPRB icon
2
Spruce Biosciences
SPRB
$119M
$8.6M 31.72%
39,150
– –
2020 Q4
12 quarters
OKUR icon
3
OnKure Therapeutics
OKUR
$91.1M
$4.05M 14.95%
253,422
– –
2021 Q2
10 quarters
XLO icon
4
Xilio Therapeutics
XLO
$58.6M
$793K 2.92%
102,960
– –
2021 Q4
8 quarters
VAPO
5
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$52.6K 0.19%
52,552
– –
2020 Q4
12 quarters

Similar funds

RiverVest Venture Management's Q4 2023 Portfolio in Review

As of Q4 2023, RiverVest Venture Management held 5 positions worth $27.1M, down 33% from $40.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 0%. RiverVest Venture Management opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • RiverVest Venture Management's ten largest holdings make up 100% of its $27.1M portfolio in Q4 2023.
  • RiverVest Venture Management opened 0 new positions and closed 0 in Q4 2023.
  • RiverVest Venture Management's portfolio value fell 33% quarter-over-quarter to $27.1M.

Based on RiverVest Venture Management's 13F filing for Q4 2023, filed 12 Feb 2024.